Published in J Am Coll Surg on September 19, 2009
The contemporary role of blood products and components used in trauma resuscitation. Scand J Trauma Resusc Emerg Med (2010) 0.98
Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis. CMAJ (2010) 0.98
Trauma care today, what's new? Int J Crit Illn Inj Sci (2011) 0.76
Risk of Bleeding in End-Stage Liver Disease Patients Undergoing Cardiac Catheterization. Tex Heart Inst J (2015) 0.75
Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation (2002) 2.33
Surgical treatment of postinfarction left ventricular pseudoaneurysm. Ann Thorac Surg (2007) 2.26
Surgical treatment of pseudoaneurysm of the thoracic aorta. J Thorac Cardiovasc Surg (2006) 1.88
Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. Ann Thorac Surg (2006) 1.59
The first Latin-American risk stratification system for cardiac surgery: can be used as a graphic pocket-card score. Interact Cardiovasc Thorac Surg (2009) 1.40
The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation. J Thorac Cardiovasc Surg (2005) 1.27
Solitary massive right ventricular metastasis of renal cell carcinoma without inferior vena cava or right atrium involvement. J Card Surg (2006) 1.25
Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg (2006) 1.08
Hemodynamic and metabolic changes during exercise in calves with total artificial hearts of different sizes yet similar output. Artif Organs (2007) 0.94
Effects of surgical ventricular restoration on left ventricular contractility assessed by a novel contractility index in patients with ischemic cardiomyopathy. Am J Cardiol (2008) 0.92
Outcomes of axillary artery side graft cannulation for extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg (2012) 0.92
Regional referral system for patients with acute mechanical support: experience at the Cleveland Clinic Foundation. ASAIO J (2006) 0.92
Analysis of patient-specific surgical ventricular restoration: importance of an ellipsoidal left ventricular geometry for diastolic and systolic function. J Appl Physiol (1985) (2013) 0.89
Human clinical fitting study of the DexAide right ventricular assist device. Artif Organs (2009) 0.84
Corneal crosslinking with genipin, comparison with UV-riboflavin in ex-vivo model. Mol Vis (2012) 0.82
CT-based diagnosis of diffuse coronary artery disease on the basis of scaling power laws. Radiology (2013) 0.82
Ventricular assist devices and aggressive immunosuppression: looking beyond overall survival. J Heart Lung Transplant (2006) 0.80
Replacement of the left-side valves of an implanted total artificial heart. ASAIO J (2006) 0.80
Letter by Al-Ruzzeh and Navia regarding article, "Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery". Circulation (2010) 0.77
A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection. J Surg Res (2007) 0.77
Myocardial infarction secondary to a coronary ostial thrombus in antiphospholipid syndrome. Ann Thorac Surg (2007) 0.77
Reduction of mitral regurgitation using the Coapsys device: a novel ex vivo method using excised recipients' hearts. ASAIO J (2005) 0.76
One hundred days or more bridged on a ventricular assist device and effects on outcomes following heart transplantation. Eur J Cardiothorac Surg (2008) 0.76
Contemporary outcomes of outpatients referred for cardiac transplantation evaluation to a tertiary heart failure center: impact of surgical alternatives. J Card Fail (2004) 0.76
Early and midterm risk of coronary allograft vasculopathy in patients bridged to orthotopic heart transplantation with ventricular assist devices. Transplantation (2005) 0.76
Successful management of a posterior saccular coronary artery aneurysm at the left main coronary artery bifurcation. J Card Surg (2011) 0.76
Renal cell carcinoma with extensive cavoatrial involvement. J Heart Valve Dis (2013) 0.75
Simulation Based Design and Evaluation of a Transcatheter Mitral Heart Valve Frame. J Med Device (2012) 0.75
Transcatheter Mitral Valve Replacement of NaviGate Bioprosthesis in A Preclinical Model. EuroIntervention (2017) 0.75
Con: The role of recombinant factor VIIa in the control of bleeding after cardiac surgery. J Cardiothorac Vasc Anesth (2008) 0.75
Performance of bioprosthetic valves after glycerol dehydration, ethylene oxide sterilization, and rehydration. Innovations (Phila) (2011) 0.75
Preload-adjusted right ventricular maximal power: concept and validation. Am J Physiol Heart Circ Physiol (2004) 0.75
Caution with the published database reviews analyzing the off-label use of recombinant activated factor VII (rFVIIa) in cardiac surgery. Transfus Apher Sci (2010) 0.75
Reply: The Spotlight Is on Secondary Access for TAVR: Radial Versus Femoral Revisited. JACC Cardiovasc Interv (1) 0.75
Complications of percutaneous mitral balloon valvotomy: usefulness of real-time 3-dimensional technology. J Cardiothorac Vasc Anesth (2011) 0.75
Combined minimally invasive pulmonary vein isolation, left atrial appendage excision and cardiac resynchronization therapy for heart failure: case report. Heart Surg Forum (2005) 0.75